ProfileGDS4718 / 219006_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 85% 82% 83% 81% 82% 92% 94% 86% 79% 85% 87% 76% 92% 94% 93% 86% 87% 91% 91% 80% 82% 83% 85% 86% 82% 91% 86% 88% 81% 91% 83% 90% 79% 84% 91% 94% 91% 86% 85% 84% 87% 90% 87% 94% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.5538685
GSM549102patient 115, normal, homogenized [OPG study]7.9920282
GSM549104patient 119, normal, homogenized [OPG study]8.3250883
GSM549108patient 138, normal, homogenized [OPG study]7.9024581
GSM549119patient 077, normal, homogenized [OPG study]8.0092982
GSM549133patient 032, cancer, homogenized [OPG study]9.646792
GSM549139patient 042, cancer, homogenized [OPG study]9.8981494
GSM549099patient 107, normal, homogenized [OPG study]8.5138186
GSM549109patient 139, normal, homogenized [OPG study]7.6701579
GSM549110patient 046, normal, homogenized [OPG study]8.4366985
GSM549114patient 063, normal, homogenized [OPG study]8.895587
GSM549122patient 082, normal, homogenized [OPG study]7.4256576
GSM549134patient 033, cancer, homogenized [OPG study]9.5908792
GSM549136patient 036, cancer, homogenized [OPG study]10.043994
GSM549140patient 044, cancer, homogenized [OPG study]9.8245993
GSM549111patient 047, normal, homogenized [OPG study]8.6953986
GSM549113patient 057, normal, homogenized [OPG study]8.8290887
GSM549132patient 031, cancer, homogenized [OPG study]9.3654291
GSM549137patient 038, cancer, homogenized [OPG study]9.343691
GSM549142patient 047, cancer, homogenized [OPG study]7.6108680
GSM549100patient 110, normal, homogenized [OPG study]7.9785482
GSM549107patient 135, normal, homogenized [OPG study]8.1896983
GSM549115patient 068, normal, homogenized [OPG study]8.5737485
GSM549116patient 072, normal, homogenized [OPG study]8.6888886
GSM549120patient 078, normal, homogenized [OPG study]8.1433282
GSM549131patient 030, cancer, homogenized [OPG study]9.4213191
GSM549118patient 074, normal, homogenized [OPG study]8.6019186
GSM549129patient 027, cancer, homogenized [OPG study]8.784888
GSM549123patient 088, normal, homogenized [OPG study]7.9807781
GSM549124patient 006, cancer, homogenized [OPG study]9.2388291
GSM549126patient 015, cancer, homogenized [OPG study]8.173683
GSM549128patient 025, cancer, homogenized [OPG study]9.2020590
GSM549103patient 117, normal, homogenized [OPG study]7.6062279
GSM549117patient 073, normal, homogenized [OPG study]8.3812684
GSM549138patient 041, cancer, homogenized [OPG study]9.4301991
GSM549141patient 045, cancer, homogenized [OPG study]9.9419894
GSM549130patient 028, cancer, homogenized [OPG study]9.1926591
GSM549101patient 111, normal, homogenized [OPG study]8.5309686
GSM549105patient 128, normal, homogenized [OPG study]8.4562885
GSM549106patient 134, normal, homogenized [OPG study]8.5120184
GSM549112patient 048, normal, homogenized [OPG study]8.8015587
GSM549125patient 011, cancer, homogenized [OPG study]9.062690
GSM549127patient 024, cancer, homogenized [OPG study]8.6357587
GSM549135patient 035, cancer, homogenized [OPG study]9.9037294